BANTAM PHARMACEUTICAL LLC has a total of 34 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2013. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Brazil. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are CASTRO ALFREDO C, FLATLEY DISCOVERY LAB LLC and ARVINAS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | United States | 5 | |
#3 | Brazil | 4 | |
#4 | EPO (European Patent Office) | 4 | |
#5 | Israel | 4 | |
#6 | Canada | 3 | |
#7 | China | 3 | |
#8 | Mexico | 3 | |
#9 | Australia | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Ciblat Stephane | 18 |
#2 | Grand-Maitre Chantal | 17 |
#3 | Cooper Alan B | 16 |
#4 | Shipps Gerald W | 15 |
#5 | Luther Michael | 13 |
#6 | Dery Martin | 12 |
#7 | Constantineau-Forget Lea | 12 |
#8 | Bruneau-Latour Nicolas | 12 |
#9 | Srivastava Sanjay | 11 |
#10 | Oza Vibha | 11 |
Publication | Filing date | Title |
---|---|---|
WO2020243584A1 | Crystalline polymorphs of a 1-thiazol-2-yl-pyrazole-5-carboxylic acid derivative | |
WO2020243582A1 | Methods for making thiszolylpyrazole carboxylic acids and intermediates therefor | |
WO2019236966A2 | Methods of treatment of cancer with substituted pyrrole and pyrazole compounds and diagnosis of cancers susceptible to treatment with substituted pyrrole and pyrazole compounds | |
MX2019006299A | Substituted pyrazole compounds and methods of using them for treatment of hyperproliferative diseases. | |
EP3548024A2 | Methods of using substituted pyrazole and pyrazole compounds and for treatment of hyperproliferative diseases | |
BR112017025851A2 | substituted pyrazole and pyrrol compounds and methods for using them for inhibition of translation initiation and treatment of related diseases and disorders | |
AU2013334860A1 | Compositions and methods for treating or preventing diseases or disorders associated with misregulated elF4E |